NEUTRAMAXX 5000 TRI-CALCIUM PHOSPHATE- sodium fluoride paste, dentifrice
NEUTRAMAXX 5000 by
Drug Labeling and Warnings
NEUTRAMAXX 5000 by is a Prescription medication manufactured, distributed, or labeled by Massco Dental A Division of Dunagin Pharmaceuticals. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
- Drug FactsActive Ingredients
- DESCRIPTION:
- Purpose
- Keep Out of Reach of Children.
- CLINICAL PHARMACOLOGY:
-
INDICATIONS AND USAGE:
NeutraMaxx™ 5000 with Tri-Calcium Phosphate is a self applied dentifrice for prevention of tooth decay, orthodontic decalcification and hypersensitivity
A dental caries preventive; for once daily self-applied topical use. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators. 1-4 NeutalMaxx™ brand of 1.1% sodium fluoride in a squeeze tube is easily applied onto a toothbrush. This prescription dental cream should be used once daily in place of your regular toothpaste unless otherwise instructed by your dental professional. May be used whether or not drinking water is fluoridated, since topical fluoride cannot produce fluorisis. (See WARNINGS for exceptions)
-
WARNINGS:
Prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under 6 years, especially if the water fluoridation exceeds 0.6 ppm, since younger pediatric patients frequently cannot preform the brushing process without significant swallowing. Use in pediatric patients under 6 years requires special supervision to prevent repeated swallowing of the cream which could cause dental fluorosis. Read directions carefully before using. Keep out of reach of infants and children.
Warnings
- Do not swallow
- For topical use only
- As with all medications, keep out of reach of children
- PRECAUTIONS:
-
Carcinogenesis, Mutagenesis, Impairment of Fertility:
In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogensesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of boby weight. Epidemiological data provide no credible evidence for an assocoation between Fluoride, either naturally occuring or added to drinking water, and the risk of human cancer. Fluoride ion is not mutagenic in standard bacterial systems. It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. Invivo data exposure in humans have not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5mg/kg of body weight) do not resule in impaired fertility and reproductive capabilities.
-
Pregnancy:
Pregnancy Catagory B. It has shown that fluoride crosses the placenta of rats, bot only 0.01% of the amount administered in incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg body weight (rabbits) did not affect the litter size of fetal weight and did not increase the frequency of sheletal or visceral malformations. Epidemiologiical studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during utero development may result in skeletal fluorosis, which becomes evident in childhood.
-
Nursing Mothers:
It is not known if fluoride is excreted in human milk. However,many drugs are excreted in milk, and caution should be exercised when product containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing high concentration of fluoride (96-137 mg/kg of body weight). No adverse effects on parturition, lactation or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.
-
Pediatric Use:
The use of NeutraMaxx™ in pediatric age group 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium Fluoride gets in mouth trays in students age 11 - 14 years conducted by Englander, et al. 2, 3, 4 Safety and effectiveness in pediatric patients below the age of 6 years have not been established. Please refer to CONTRAINDICATIONS and WARNINGS sections.
- ADVERSE REASTIONS:
-
OVERDOSE:
Accidential ingestion of large amounts of fluoride may result in acute burning of the mouth and sore tongue. Nausea, vomiting and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salvation, hematemesis and epigastric cramping and abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg of body weight (i.e. less than 2.3 mg fluoride/kg of body weight) have been ingested, induce emesis, give oral soluble calcium (e.g. milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more that 15 mg fluoride/kg of body weight (i.e. more than 6.9 mg fluoride/kg of body weight), induce vomiting and admit immediately to a hospital facility.
-
DOSAGE AND ADMINISTRATION:Directions: Use As Directed
This prescription dentifrice is recommended for adults and pediatric patients 6 years and older
- Apply a thin ribbon of NeutraMaxxtm 5000 TCP along the length of the toothbrush no more than "pea size" total dose. Brush for two minutes.
- After brushing ADULTS - Expectorate, do not eat for 30 minutes. CHILDREN 6 YEARS OF AGE OR OLDER - Expectorate and rinse mouth with water. Rinse mouth thoroughly.
- Use at bedtime in place of your regular toothpaste or as directed by your dental professional.
Follow these instructions unless otherwise instructed by you dental professional.
- HOW SUPPLIES:
- STORAGE:
- Inactive Ingredients:
- Questions? Comments? Section
-
NeutraMaxxC TCP VANILLA MINT
NDS 63783 63783-502-04
VANILLA MINT FLAVOR
ANTI-CAVITY TOOTHPASTE XYLITOL
NeutraMaxx™5000 TRI-CALCIUM PHOSPHATE
1.1% Neutral Sodium Fluoride 5000 ppm
Sweetened with Xylitol
DOES NOT CONTAIN SODIUM LAURYL SULFATE
RX ONLY
Net wt. 4 oz (112 G)
Manufactured By:
MASSCO DENTAL
A Division of Dunagin Pharmaceuticals,
Rogers, AR
800-227-1296 www.masscodental.net
-
INGREDIENTS AND APPEARANCE
NEUTRAMAXX 5000 TRI-CALCIUM PHOSPHATE
sodium fluoride paste, dentifriceProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC: 63783-502 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM FLUORIDE (UNII: 8ZYQ1474W7) (FLUORIDE ION - UNII:Q80VPU408O) FLUORIDE ION 1.1 g in 112 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) SORBITOL (UNII: 506T60A25R) HYDRATED SILICA (UNII: Y6O7T4G8P9) GLYCERIN (UNII: PDC6A3C0OX) POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B) CARBOXYMETHYLCELLULOSE (UNII: 05JZI7B19X) XYLITOL (UNII: VCQ006KQ1E) SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) SACCHARIN SODIUM (UNII: SB8ZUX40TY) TRIBASIC CALCIUM PHOSPHATE (UNII: 91D9GV0Z28) Product Characteristics Color Score Shape Size Flavor VANILLA (VANILLA MINT) Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 63783-502-04 112 g in 1 TUBE; Type 0: Not a Combination Product 08/01/2011 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 08/01/2011 Labeler - Massco Dental A Division of Dunagin Pharmaceuticals (008081858) Registrant - Massco Dental A Division of Dunagin Pharmaceuticals (008081858) Establishment Name Address ID/FEI Business Operations Massco Dental A Division of Dunagin Pharmaceuticals 008081858 manufacture(63783-502)
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.